X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

Study: SMRT Sequencing Can Improve the Safety of Gene Therapy Protocols

Thursday, March 15, 2018

A new publication in the journal of the American Society of Gene & Cell Therapy demonstrates the novel use of SMRT Sequencing for improving the safety and quality of a type of gene therapy delivered through a viral vector. The work established new quality control standards and revealed previously undetected risks for gene therapy delivery.

Adeno-Associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras,” published in Molecular Therapy — Methods & Clinical Development, comes from lead author Phillip Tai, senior author Guangping Gao, and collaborators from the University of Massachusetts Medical School and other institutions. The team aimed to characterize the adeno-associated virus (AAV) vectors that have gained traction recently as delivery vehicles for gene therapy. Previously, there had been no reliable, comprehensive method for assessing the integrity of those AAV vectors prior to introducing them to patients.

The team used PacBio long-read sequencing to analyze a population of AAV vectors, providing the first high-resolution view of the DNA sequences they would deliver to a patient. They found more problems than expected: some vectors contained less than half of the DNA sequence they should have, while genetic errors called chimeras were discovered in other vectors. In a patient, these vectors would have reduced the likelihood of successful gene therapy outcomes.

With this approach, known as AAV-genome population sequencing or AAV-GPseq, “we can comprehensively profile packaged genomes as a single intact molecule and directly assess vector integrity without extensive preparation,” the scientists report. This detailed view allowed the team to spot reverse-packaged genomes, chimeras with inverted terminal repeat-containing sequences, and truncated genomes. “These discoveries redefine quality control standards for viral vector preparations and highlight the degree of foreign products in [recombinant AAV]-based therapeutic vectors,” the team writes.

The full AAV-GPseq method is available and “can be easily adapted for research-grade and clinical vector manufacturing QC pipelines,” the scientists add.

Subscribe for blog updates:

Archives